Part I . Overview We are a global performance beauty company delivering breakthrough products with a customer-centric approach. Our primary market is the cash-pay aesthetic market, which consists of medical products that consumers pay for directly out of pocket. Our customers are aesthetic practitioners who are properly licensed to deliver our products. By avoiding the regulatory burdens that accompany reimbursed products and pursuing an aesthetic-only non-reimbursed product strategy, we believe...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2025-12-31 | 0001628280-26-014001 | EDGAR | 64K words |
| 2025-03-04 | 2024-12-31 | 0001570562-25-000020 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0001570562-24-000041 | EDGAR | — |
| 2023-03-08 | 2022-12-31 | 0001570562-23-000038 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001570562-22-000067 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001570562-21-000093 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001570562-20-000061 | EDGAR | — |
| 2019-03-20 | 2018-12-31 | 0001570562-19-000038 | EDGAR | — |
| 2018-03-29 | 2017-12-31 | 0001570562-18-000013 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001628280-26-053468 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001628280-25-049673 | EDGAR | 47K words |
| 2025-08-05 | 2025-06-30 | 0001570562-25-000098 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001570562-25-000075 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001570562-24-000128 | EDGAR | — |
| 2024-07-31 | 2024-06-30 | 0001570562-24-000116 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001570562-24-000080 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001570562-23-000115 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0001570562-23-000088 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001570562-23-000070 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001570562-22-000143 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001570562-22-000119 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001628280-26-053384 | EDGAR | — |
| 2026-08-04 | 0001570562-26-000083 | EDGAR | — |
| 2026-03-13 | 0001570562-26-000043 | EDGAR | 1K words |
| 2026-03-03 | 0001628280-26-013872 | EDGAR | — |
| 2026-01-09 | 0001570562-26-000003 | EDGAR | — |
| 2025-11-05 | 0001628280-25-049564 | EDGAR | — |
| 2025-09-08 | 0001570562-25-000110 | EDGAR | — |
| 2025-08-05 | 0001570562-25-000094 | EDGAR | — |
| 2025-06-06 | 0001570562-25-000085 | EDGAR | — |
| 2025-05-27 | 0001570562-25-000083 | EDGAR | — |
156 total filings indexed. 125 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001570562 |
| Ticker | EOLS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.evolus.com |
| Listed | 2018-02-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/EOLS (~200 tokens, structured JSON with cryptographic provenance)